These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings. Kawada T Alzheimer Dis Assoc Disord; 2023 Jul-Sep 01; 37(3):265. PubMed ID: 37561964 [No Abstract] [Full Text] [Related]
3. Medication for schizophrenia. Gray R Nurs Times; 2001 Aug 2-8; 97(31):38-9. PubMed ID: 11957534 [No Abstract] [Full Text] [Related]
5. The Impact of Cholinesterase Inhibitors with or without Memantine on Antipsychotic Prescribing. Blaszczyk AT; Mang BH; Garza H; Mathys M Consult Pharm; 2018 May; 33(5):273-282. PubMed ID: 29789049 [TBL] [Abstract][Full Text] [Related]
6. Studies shed light on risks and trends in pediatric antipsychotic prescribing. Kuehn BM JAMA; 2010 May; 303(19):1901-3. PubMed ID: 20483961 [No Abstract] [Full Text] [Related]
7. A guide to prescribing anti-dementia medication. Kennedy S; Sud D Nurs Times; 2014 Jun 4-10; 110(23):16-8. PubMed ID: 25016734 [TBL] [Abstract][Full Text] [Related]
8. Rethinking medical audit: the goal is efficiency. Mooney G; Ryan M J Epidemiol Community Health; 1992 Jun; 46(3):180-3. PubMed ID: 1645066 [No Abstract] [Full Text] [Related]
9. Challenges and pitfalls of antipsychotic prescribing in people with learning disability. Alexander RT; Shankar R; Cooper SA; Bhaumik S; Hastings R; Kapugama CL; Tromans SJ; Roy A Br J Gen Pract; 2017 Aug; 67(661):372-373. PubMed ID: 28751349 [No Abstract] [Full Text] [Related]
10. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice. Paton C; Bhatti S; Purandare K; Roy A; Barnes T BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085 [TBL] [Abstract][Full Text] [Related]
11. Thrombolysis in accident and emergency: the exception not the rule. Are we denying patients lifesaving treatment? Quinn T Accid Emerg Nurs; 1999 Jan; 7(1):39-41. PubMed ID: 10232113 [No Abstract] [Full Text] [Related]
12. Antipsychotic polypharmacy in psychiatric practice: is it really doomed? Naguy A Australas Psychiatry; 2017 Apr; 25(2):200-201. PubMed ID: 28375065 [No Abstract] [Full Text] [Related]
14. The evolving clinical profile of atypical antipsychotic medications. Buckley PF; Miller DD; Singer B; Donenwirth K Can J Psychiatry; 2001 Apr; 46(3):285. PubMed ID: 11320683 [No Abstract] [Full Text] [Related]
15. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study. Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209 [TBL] [Abstract][Full Text] [Related]
16. Doctor performance and public accountability. Osborn S; Williams S Lancet; 2004 Jan; 363(9403):171-2. PubMed ID: 14726187 [No Abstract] [Full Text] [Related]
17. Using advocacy to safeguard older people with learning disabilities. Jenkins R Nurs Older People; 2012 Jul; 24(6):31-6. PubMed ID: 22900394 [TBL] [Abstract][Full Text] [Related]
19. Antipsychotics for behavioral and psychiatric symptoms of dementia: a reaudit in a specialist inpatient service. Haw C; Stoffels M; Purkayastha DD; Sudad S Int Psychogeriatr; 2015 Jan; 27(1):171-2. PubMed ID: 24990598 [No Abstract] [Full Text] [Related]
20. Side Effects of Antipsychotic Medications: Physician's Choice of Medication and Patient Compliance. Dallas, Texas, California. January 22, 1999. Proceedings of a roundtable. J Clin Psychiatry; 2000; 61 Suppl 8():3-66; quiz 67-70. PubMed ID: 10811236 [No Abstract] [Full Text] [Related] [Next] [New Search]